Neuland Laboratories Ltd. plans to open a commercial-scale peptide manufacturing facility in summer 2026 at its 17-acre Bonthapally campus in Hyderabad, India. The expansion aims...The post Neuland Laboratories Plans Commercial Peptide Manufacturing Facility Opening in Summer 2026 appeared first on PharmaSource.
Neuland Laboratories Plans Commercial Peptide Manufacturing Facility Opening in Summer 2026